<DOC>
	<DOC>NCT01375127</DOC>
	<brief_summary>This is an observational study designed to collect follow-up clinical date on subjects who were treated with tofacitinib in 2 completed Phase 2 studies who either discontinued treatment prematurely or did not elect to enroll in long-term extension studies.</brief_summary>
	<brief_title>Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients</brief_title>
	<detailed_description>Subjects are identified based on whether they received tofacitinib in 2 completed Phase 2 studies who either discontinued treatment prematurely or who did not elect to enroll in long-term extension studies. Subjects are pre-identified</detailed_description>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects have discontinued tofacitinib prior to the planned treatment duration in 2 completed Phase 2 studies; or have not enrolled in longterm extension studies. No other subjects are eligible for this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Observational</keyword>
	<keyword>clinical follow-up data</keyword>
</DOC>